Silverarc Capital Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.7M | Buy |
2,022,482
+641,324
| +46% | +$8.79M | 5.11% | 4 |
|
|
2025
Q1 | $15.3M | Buy |
1,381,158
+260,685
| +23% | +$2.88M | 3.12% | 10 |
|
|
2024
Q4 | $11.9M | Buy |
1,120,473
+219,344
| +24% | +$2.34M | 2.61% | 13 |
|
|
2024
Q3 | $11.4M | Sell |
901,129
-200,871
| -18% | -$2.55M | 2.57% | 12 |
|
|
2024
Q2 | $18.5M | Buy |
1,102,000
+593,413
| +117% | +$9.96M | 4.36% | 4 |
|
|
2024
Q1 | $7.63M | Sell |
508,587
-16,817
| -3% | -$252K | 2.12% | 16 |
|
|
2023
Q4 | $7.88M | Buy |
525,404
+16,521
| +3% | +$248K | 2.35% | 14 |
|
|
2023
Q3 | $7.13M | Buy |
+508,883
| New | +$7.13M | 2.16% | 11 |
|